⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL28214043 | 0.71 | — | — | |
| Phosphine SCHEMBL30340926 | 0.71 | — | — | |
| Bromide SCHEMBL28299354 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL3980396 | 0.71 | — | — | |
| SCHEMBL31148891 | 0.71 | — | — | |
| Potassium Ion SCHEMBL23462163 | 0.00 | CA4 (0.50) | — | |
| SCHEMBL25435013 | 0.00 | — | — | |
| SCHEMBL25435790 | 0.00 | — | — | |
| SCHEMBL25436537 | 0.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL25435623 | 0.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024102332-A1 | VACCINE COMPOSITIONS COMPRISING A NEOANTIGEN OF KRAS | HIMV LLC (US) | 2024-05-16 | — | — | WO | disclosed |
| EP-3619530-A1 | SYSTEMS AND METHODS FOR POST-HARVEST CROP QUALITY AND PEST MANAGEMENT | Centaur Analytics, Inc. (US) | 2020-03-11 | — | — | EP | disclosed |
| EP-3615701-A2 | SHAPE MEMORY ARTICLES AND METHODS FOR CONTROLLING PROPERTIES | Medtronic Inc. (US) | 2020-03-04 | — | — | EP | disclosed |
| WO-2019006466-A1 | COMPOSITIONS AND METHODS FOR LARGE-SCALE IN VITRO PLANT BIOCULTURE | BOOSHOOT LLC (US) | 2019-01-03 | — | — | WO | disclosed |
| WO-2018204400-A1 | SYSTEMS AND METHODS FOR POST-HARVEST CROP QUALITY AND PEST MANAGEMENT | Centaur Analytics, Inc. (US) | 2018-11-08 | — | — | WO | disclosed |
| WO-2018201111-A2 | SHAPE MEMORY ARTICLES AND METHODS FOR CONTROLLING PROPERTIES | MEDTRONIC INC. (US) | 2018-11-01 | — | — | WO | disclosed |
| EP-3384024-A2 | MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY | Crispr Therapeutics AG (CH) | 2018-10-10 | — | — | EP | disclosed |
| EP-3302382-A1 | IMPLANT FOR TREATMENT OF AN OCULAR CONDITION | ALLERGAN, INC. (US) | 2018-04-11 | — | — | EP | disclosed |
| WO-2017093804-A2 | MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY | CRISPR THERAPEUTICS AG (CH) | 2017-06-08 | — | — | WO | disclosed |
| WO-2016196365-A1 | IMPLANT FOR TREATMENT OF AN OCULAR CONDITION | ENVISIA THERAPEUTICS, INC. (US) | 2016-12-08 | — | — | WO | disclosed |
| EP-1979329-A2 | 4-ARYL-2-AMINO-PYRIMIDINES OR 4-ARYL-2-AMINOALKYL-PYRIMIDINES AS JAK-2 MODULATORS AND METHODS OF USE | Exelixis, Inc. (US) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007089768-A2 | 4-ARYL-2-AMINO-PYRIMIDINES OR 4-ARYL-2-AMINOALKYL-PYRIMIDINES AS JAK-2 MODULATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | EXELIXIS, INC. (US) | 2007-08-09 | — | — | WO | disclosed |
| WO-2007047569-A1 | VIRTUAL ENVIRONMENTS | LEVIATHAN ENTERTAINMENT (US) | 2007-04-26 | — | — | WO | disclosed |